A Passion For Infectious Disease Education and Communication
Tim Gauthier PharmD, BCPS, BCIDP, began his career in academia, and although he has transitioned to working in a health system he has never left behind his passion about education around pathogens, antibiotics, and stewardship. He has 2 websites, ID Stewardship and Learn Antibiotics, on these topics and it has really allowed him to continue […]
Merck Launches Phase 3 Trial of Single-Dose Dengue Vaccine Candidate V181
Merck Research Laboratories logo Image credits: Merck Merck has initiated MOBILIZE-1, the first phase 3 clinical trial of its investigational dengue vaccine candidate, V181, to evaluate its safety, immunogenicity, and efficacy in preventing dengue caused by all four virus serotypes, regardless of prior exposure. Enrollment has begun in Singapore, with the study targeting approximately 12,000 […]
Professional Societies Must Address Gaps When Politics Overrides Evidence
With the ongoing current events related to vaccine policy, we decided to post this early release, of the Summer issue’s Editor-in-Chief letter. “May you live in interesting times,” often cited incorrectly as a Chinese curse, is an idiom that has felt particularly apt of late. Our field faces new and significant challenges: grant cancellations, reduced […]
Successful HCV Treatment with DAAs Linked to Lower Extrahepatic Manifestation Risk
Naveed Zafar Janjua, MBBS, DrPH Credit: Centre for Advancing Health Outcomes This article was originally posted on our sister site, HCPLive.com Successful hepatitis C virus (HCV) treatment with direct-acting antivirals (DAAs) is associated with a reduced risk of several extrahepatic manifestations (EHMs), according to findings from a recent study.1 Leveraging data from the BC Hepatitis […]
Scientists discover llama antibodies that shut down COVID — and its future variants
Scientists have discovered a unique class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous early and recent SARS-CoV-2 variants. The unique antibodies target an essential highly conserved site at the base of the virus’s spike protein, effectively clamping it shut and preventing the virus from […]
Early Release – Assessing Readiness of International Investigations into Alleged Biological Weapons Use – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Spiez Laboratory, Spiez, Switzerland (M. Brackmann, C. Invernizzi); Robert Koch Institute, Berlin, Germany (A. Blasse, S. Kloth, I. Mergler); Biological Defense Laboratory, Lisbon, Portugal (J.G. […]
Early Release – Epidemiologic and Genomic Investigation of Sexually Transmitted Shigella sonnei, England – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: United Kingdom Health Security Agency, London, UK (H. Charles, D.R. Greig, C. Swift, I. Olonade, I. Simms, K. Sinka, G. Godbole, C. Jenkins); University of […]
Early Release – Emergence of Distinct Salmonella enterica Serovar Enteritidis Lineage since 2020, South Korea – Volume 31, Number 7—July 2025 – Emerging Infectious Diseases journal
Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released. Author affiliation: Korea Centers for Diseases Control and Prevention Agency, Cheongju, South Korea (E. Shin, J. Yoo, J. Kim); Konkuk University College of Veterinary Medicine, Seoul, South […]
